A detailed history of Ancora Advisors, LLC transactions in Organon & Co. stock. As of the latest transaction made, Ancora Advisors, LLC holds 13,635 shares of OGN stock, worth $200,843. This represents 0.01% of its overall portfolio holdings.

Number of Shares
13,635
Previous 13,634 0.01%
Holding current value
$200,843
Previous $282,000 7.8%
% of portfolio
0.01%
Previous 0.01%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$18.65 - $23.03 $18 - $23
1 Added 0.01%
13,635 $260,000
Q1 2024

May 15, 2024

SELL
$13.78 - $18.8 $895 - $1,222
-65 Reduced 0.47%
13,634 $256,000
Q4 2023

Feb 14, 2024

SELL
$10.95 - $17.32 $1.49 Million - $2.35 Million
-135,869 Reduced 90.84%
13,699 $197,000
Q3 2023

Nov 14, 2023

SELL
$16.59 - $23.77 $616,948 - $883,958
-37,188 Reduced 19.91%
149,568 $2.6 Million
Q2 2023

Aug 14, 2023

SELL
$19.27 - $24.63 $170,828 - $218,344
-8,865 Reduced 4.53%
186,756 $3.89 Million
Q1 2023

May 15, 2023

SELL
$21.42 - $32.08 $2.37 Million - $3.55 Million
-110,548 Reduced 36.11%
195,621 $4.6 Million
Q4 2022

Feb 14, 2023

BUY
$23.31 - $28.61 $1.95 Million - $2.4 Million
83,830 Added 37.7%
306,169 $8.55 Million
Q3 2022

Nov 14, 2022

SELL
$23.4 - $34.25 $1.64 Million - $2.4 Million
-70,169 Reduced 23.99%
222,339 $5.2 Million
Q2 2022

Aug 15, 2022

SELL
$31.66 - $38.9 $206,613 - $253,861
-6,526 Reduced 2.18%
292,508 $9.87 Million
Q1 2022

May 16, 2022

BUY
$30.45 - $39.36 $9.11 Million - $11.8 Million
299,034 New
299,034 $10.4 Million
Q1 2022

May 13, 2022

SELL
$30.45 - $39.36 $8.93 Million - $11.5 Million
-293,428 Closed
0 $0
Q4 2021

Feb 14, 2022

BUY
$28.67 - $37.13 $603,044 - $780,992
21,034 Added 7.72%
293,428 $8.94 Million
Q3 2021

Nov 15, 2021

BUY
$28.63 - $35.64 $7.67 Million - $9.55 Million
268,015 Added 6120.46%
272,394 $8.93 Million
Q2 2021

Aug 13, 2021

BUY
$28.45 - $38.0 $124,582 - $166,402
4,379 New
4,379 $133,000

Others Institutions Holding OGN

About Organon & Co.


  • Ticker OGN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 254,330,000
  • Market Cap $3.75B
  • Description
  • Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...
More about OGN
Track This Portfolio

Track Ancora Advisors, LLC Portfolio

Follow Ancora Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ancora Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ancora Advisors, LLC with notifications on news.